Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.

被引：18

作者：

Al-Batran, Salah-Eddin ^{[1
]}

Reichart, Alexander ^{[2
]}

Bankstahl, Ulli Simone ^{[1
]}

Pauligk, Claudia ^{[1
]}

Kraus, Thomas Werner ^{[3
]}

Bechstein, Wolf Otto ^{[4
]}

Trojan, Jorg ^{[5
]}

Behrend, Matthias ^{[6
]}

Potenberg, Jochem ^{[7
]}

Homann, Nils ^{[8
]}

Venerito, Marino ^{[9
]}

Bohle, Wolfram ^{[10
]}

Varvenne, Michael ^{[11
]}

Bolling, Claus ^{[12
]}

Behringer, Dirk M. ^{[13
]}

Kratz-Alber, Karsten ^{[14
]}

Siegler, Gabriele Margareta ^{[15
]}

Hozaeel, Wael ^{[1
]}

Goetze, Thorsten Oliver ^{[1
]}

机构：

[1] Univ Canc Ctr Frankfurt, Inst Klin Onkol Forsch Krankenhaus Nordwest, Frankfurt, Germany

[2] Rems Murr Klinikum Winnenden, Winnenden, Germany

[3] Krankenhaus Nordwest GmbH, Allgemein Viszeral & Minimal Invas Chirurg, Frankfurt, Germany

[4] Univ Hosp Frankfurt, Dept Gen & Visceral Surg, Frankfurt, Germany

[5] Univ Hosp Frankfurt, Frankfurt, Germany

[6] DONAUISAR Klinikum Deggendorf, Deggendorf, Germany

[7] EV Waldkrankenhaus, Berlin, Germany

[8] Klinikum Wolfsburg, Med Klin 2, Wolfsburg, Germany

[9] Univ Klinikum, Klin Gastroenterol Hepatol & Infektiol, Magdeburg, Germany

[10] Katharinenhospital, Klinikum Stuttgart, Klin Allgemeine Innere Med Gastroenterol Hepatol, Stuttgart, Germany

[11] Onkol Schwerpunktpraxis Celle, Celle, Germany

[12] Agaples Markus Hosp, Frankfurt, Germany

[13] Augusta Kranken Anstalt, Bochum, Germany

[14] Gemeinschaftspraxis Hamatol & Onkol Munster, Munster, Germany

[15] Klinikum Nurnberg Paracelsus Med Privatuniv, Nurnberg, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期

关键词：

D O I：

10.1200/JCO.2021.39.3_suppl.406

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

406

引用

页数：3